CRCAvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with CRCA, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
CRCA performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CRCA ETF 2 | -13.78%– | +25.27%– | -58.76%– | -89.50%– | n/a– | n/a– |
| Flows | CRCA ETF 2 | +$3M– | -$23M– | +$27M– | +$155M– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CRCA ETF 2 | +162.06%– | +192.95%– | n/a– | n/a– |
| Max drawdown | CRCA ETF 2 | -46.22%– | -93.00%– | n/a– | n/a– |
| Max drawdown duration | CRCA ETF 2 | 54d– | 365d– | n/a– | n/a– |
Trading data
CRCA | ETF 2 | |
Last sale | – | |
| Previous close 10/27/2026 | – | |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Replication data will be available soon
Advertisement
Main metrics
CRCA | ETF 2 | |
|---|---|---|
| Last price | – | – |
| 1D performance | – | – |
| AuM | $95.12 M | – |
| E/R | 1.08% | – |
Characteristics
CRCA | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | ProShares | – |
| Benchmark | CRCL Price | – |
| N° of holdings | - | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | August 6, 2025 | – |
| ESG | No | – |
Advertisement
Exposure
Exposure data will be available soon
Advertisement
Latest news about CRCA
Advertisement
